Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) have received a consensus recommendation of “Buy” from the six brokerages that are presently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have covered the stock in the last […]
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) has been assigned a consensus rating of “Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average 1-year price target […]